An mRNA-based flu vaccine has the potential advantage to more precisely match circulating strains, support rapid response in a future influenza pandemic, and pave the way for COVID-19 combination ...

The virus has not yet evolved to spread efficiently between people. Excellent vaccine technology exists, but the government ...

Sabic to close UK cracker, plastics recycler Novoloop raises funds, Kymera strikes molecular glue deal, and more ...

New research shows that people with worse symptoms of lactose intolerance tended to report more frequent nightmares.

Tens of thousands of people suffer needless heart attacks and strokes every year because they aren't taking ...

Recent developments that have caused concern include removing all members of a scientific committee that advises the Centers for Disease Control and Prevention (CDC) on vaccines and replacing them ...

The S&P 500 added 0.5% on Wednesday, July 2, 2025, reaching a record-high close for the second time this week as the U.S.

The U.S. Food and Drug Administration has approved three vaccines for RSV — GSK's Arexvy, Moderna's mRESVIA and Pfizer's ...

A top official at the Food and Drug Administration recently overruled government scientists on the availability of two ...

Shionogi will pay BioVersys $6.3 million for developing BV500, BioVersys's drug candidate for non-tuberculous mycobacteria.

Tariffs, uncertainty, and inflation crimped stocks in first half of 2025 after AI frenzy and strong earnings sent Nasdaq up 18% in 2024. Bet on companies Trump favors.